We lead the fight against recurrent prostate cancer
The aim of SpectraCure’s proprietary and patented treatment system is to eliminate internal cancer tumors and extend the survival of cancer patients. Our technology is based on PDT treatment with IDOSE®.
Our therapeutic system is suitable for internal solid tumours of various kinds, such as prostate and pancreas. In the future, we aim to make it possible to treat other cancers such as cancer of the breast and in the head and neck region. With our therapeutic system, the aim is to preserve a good quality of life for the patients.
The method has great potential to limit side effects, and the patient will be able to leave the hospital within a few hours after treatment. If you suffer from recurrent prostate cancer, there is often no other alternative than hormone treatment for the rest of your life. SpectraCure can now change this!